Replies to post #620 on Correvio Pharma (CORV)

[Radar02]

Institutional Ownership is over 9%. More than double the daily average volume. Someone has taken a liking to this stock.

[THREE-DAY-TRADER]

I think a lot of very bad news has already been priced into the stock (recent NASDAQ bid price warning, class action law suits, recent share offering, and prior issues with their drug in past couple months), so it fits the scenario that simply it was just due for a 'technical reversal' move upward.
In this very oversold type of scenario for $CORV, it can easily cause a strong move suddenly (short squeeze, etc.).
It's also possible some one knows news that has not yet been released. But otherwise in my experience this is a technical move following being excessively oversold and pricing in many multiple bad new items already (in the short term).

My followers via private e-mail fortunately got $CORV alerted to them 2/5 with .32 or less entry suggestion.
It's up 50-60%+ or better so far for us.
FYI ~ Since late 2017 I have not been posting most of my trades for entry publicly because I prioritize my private e-mail list, and is the reason why i have not posted here about it until now





https://stockcharts.com/c-sc/sc?s=CORV&p=D&yr=0&mn=5&dy=15&i=p94093937001&r=1580938910125